JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients

被引：0
作者：
Roberta Mancuso
Marina Saresella
Ambra Hernis
Ivana Marventano
Cristian Ricci
Simone Agostini
Marco Rovaris
Domenico Caputo
Mario Clerici
机构：
[1] ONLUS,Don C. Gnocchi Foundation
[2] University of Milan,Department of Physiopathology and Transplantation
来源：
Journal of Translational Medicine | / 10卷
关键词：
Cell mediated immunity; Natalizumab; MS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Central Nervous System Herpes Simplex and Varicella Zoster Virus Infections in Natalizumab-Treated Patients
    Fine, Andrew J.
    Sorbello, Alfred
    Kortepeter, Cindy
    Scarazzini, Linda
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : 849 - 852
  • [42] The use of cytokine signature patterns: separating drug naive, interferon and natalizumab-treated multiple sclerosis patients
    O'Connell, Kara E.
    Mok, Tzehow
    Sweeney, Brian
    Ryan, Aisling M.
    Dev, Kumlesh K.
    AUTOIMMUNITY, 2014, 47 (08) : 505 - 511
  • [43] Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients
    Rossi, Francesca
    Newsome, Scott D.
    Viscidi, Raphael
    MOLECULAR AND CELLULAR PROBES, 2015, 29 (01) : 54 - 62
  • [44] JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients
    Du Pasquier, Renaud A.
    Stein, Marion C.
    Lima, Marco A.
    Dang, Xin
    Jean-Jacques, Jims
    Zheng, Yue
    Letvin, Norman L.
    Koralnik, Igor J.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 176 (1-2) : 181 - 186
  • [45] Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy
    Lima, Marco A.
    Marzocchetti, Angela
    Autissier, Patrick
    Tompkins, Troy
    Chen, Yiping
    Gordon, Jennifer
    Clifford, David B.
    Gandhi, Rajesh T.
    Venna, Nagagopal
    Berger, Joseph R.
    Koralnik, Igor J.
    JOURNAL OF VIROLOGY, 2007, 81 (07) : 3361 - 3368
  • [46] JC virus antibody status in a pediatric multiple sclerosis cohort: Prevalence, conversion rate and influence on disease severity
    Huppke, Peter
    Hummel, Hanna
    Ellenberger, David
    Pfeifenbring, Sabine
    Stark, Wiebke
    Huppke, Brenda
    Brueck, Wolfgang
    Gaertner, Jutta
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (04) : 382 - 387
  • [47] Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis
    Herold, Tina Rike
    Jakl, Veronika
    Graser, Anno
    Eibl-Lindner, Kirsten
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1131 - 1133
  • [48] The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis
    Moller, M.
    Sondergaard, H. B.
    Koch-Henriksen, N.
    Sorensen, P. S.
    Sellebjerg, F.
    Oturai, A. B.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (01): : 27 - 31
  • [49] Natalizumab therapy is associated with changes in serum JC virus antibody indices over time
    Peters, John
    Williamson, Eric
    JOURNAL OF NEUROLOGY, 2017, 264 (12) : 2409 - 2412
  • [50] Natalizumab therapy is associated with changes in serum JC virus antibody indices over time
    John Peters
    Eric Williamson
    Journal of Neurology, 2017, 264 : 2409 - 2412
12345